Further, it provides evidence that 18α-GA treatment suppresses cell proliferation, induces G1 phase cell cycle arrest, represses metastasis, exhibits apoptotic cell death, and regulates EGFR- PI3K/AKT signaling in NSCLC cells. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.